MARC details
| 000 -LEADER |
| fixed length control field |
03139ntm a2200349 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
MY-KuUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20260123113355.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
a||||fs|||| 000 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
260123t20252025my a|||fs|||| 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
THE0010302 (Local) |
| Qualifying information |
Hardback |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
UMPSA |
| Language of cataloging |
eng |
| Transcribing agency |
UMPSA |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FIST .L49 2025 r Bc. |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Lew, Yong Yi, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
| Title |
Functional and characterisation of multi-strain probiotics in encapsulated and non-encapsulated forms of water kefir / |
| Statement of responsibility, etc. |
Lew Yong Yi |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMPSA, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2025 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Date of production, publication, distribution, manufacture, or copyright notice |
© 2025 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xv, 84 pages : |
| Other physical details |
illustrations ; |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
| Source |
rda |
| File type |
text file |
| Encoding format |
PDF |
| 500 ## - GENERAL NOTE |
| General note |
Faculty of Industrial Sciences and Technology |
| 502 ## - DISSERTATION NOTE |
| Dissertation note |
Final Year Report (Bachelor of Applied Science in Industrial Biotechnology) -- Universiti Malaysia Pahang Al-Sultan Abdullah - 2025 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
Include bibliographical reference |
| 520 3# - SUMMARY, ETC. |
| Summary, etc. |
Probiotics are living microorganisms known for their health benefits in maintaining gut health. It is empirically proven with better efficacy in multi-strain formulation than single-strain formulation. In this study, we aimed to evaluate antimicrobial, hydrophobicity, auto-aggregation, co-aggregation, acid and bile tolerance, cold tolerance, and ultrasound cavitation tolerance of a novel multi-strain formulation. Based on the result, the multi-strain formulation showed a superior antimicrobial effect on Escherichia coli (80% inhibitory effect) and the least effect on Bacillus subtilis (43.33%). On the other hand, yeast strain exhibited the highest acid tolerance, achieving a 42.52% survival rate, while lactic acid bacteria (LAB) had the lowest (32.02%). Similarly, bile tolerance tests indicated the highest survival in yeast (115.38%) and the lowest in LAB (31.42%) at 2% (w/v). Moreover, ultrasound treatment revealed an increasing growth trend under wattages, with LAB achieving its peak at 64W for 6 min (2.91±0.04). At 4℃ storage conditions, the encapsulated LAB showed the highest viable rate (64.96%), while yeast had only 21.65%. Additionally, encapsulation significantly enhanced hydrophobicity, with encapsulated probiotics showing 43.03% compared to non-encapsulated forms (24.20%). However, non-encapsulated probiotics auto-aggregation rates were higher (82.95% at 24 hours) than encapsulated forms (46.89%). Co-aggregation assays revealed pathogen-binding capacities for Serratia marcescens (40.74%) and Escherichia coli (15.28%). Overall, our study demonstrated that encapsulated multi-strain formulation has fulfilled the overall requirements for probiotic product standards. This first study that evaluates the multi-strain formulation can serve as future research groundwork. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
Faculty of Industrial Sciences and Technology |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Universities and colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Final Year Report |
| General subdivision |
Dissertations |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
http://umpir.ump.edu.my/id/eprint/45674 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Final Year Report |